Table 1.
Time (weeks) | Assessment | Experimental groups | |||
---|---|---|---|---|---|
Nondiabetic | Diabetic | ||||
Sham surgery* | Sham surgery* | 0 μg OP-1 + carrier | 25 μg OP-1 + carrier | ||
2 | Radiographic histologic | 5 | 5 | 6 | 4 |
4 | Radiographic histologic | 6 | 6 | 4 | 6 |
Biomechanical | 6 | 4 | 6 | 5 |
* Control animals in which closed fracture was created and fracture site was opened and then closed without treatment; OP-1 = osteogenic protein-1.